- Product NDC
- 42192-343
- 11-digit product format
- 421920343
- Labeler code
- 42192
- Product ID
- 42192-343_c16d9980-89fc-43da-938b-f725e2ec89a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CALCIUM CITRATE, IRON PENTACARBONYL, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, DOCUSATE SODIUM and DOCONEXENT
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Acella Pharmaceuticals, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2011-10-07
- Marketing end
- 0000-00-00
- Substance
- CALCIUM CITRATE; IRON PENTACARBONYL; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE, DL-; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; DOCUSATE SODIUM; DOCONEXENT
- Active strength
- 100 mg/1; mg/1; [iU]/1; [iU]/1; mg/1; mg/1; mg/1; mg/1
- Pharmacologic classes
- Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Vitamin D [CS],Vitamin D [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record